Vol 71, No 3 (2021)
Review paper
Published online: 2021-02-10

open access

Page views 783
Article views/downloads 654
Get Citation

Connect on Social Media

Connect on Social Media

The role of comprehensive nutritional care in cancer patients

Michał Jankowski12, Anna Qelaj1, Stanisław Kłęk3, Dawid Murawa4, Małgorzata Nartowicz1, Zbigniew Patela, Dorota Mańkowska-Wierzbicka5, Aleksandra Kapała6, Barbara Kuczyńska7, Wojciech Zegarski12
Nowotwory. Journal of Oncology 2021;71(3):158-161.

Abstract

Cancer patients often have inappropriately low energy intake, exhibit an increased loss of muscle proteins and generalized inflammatory status. Nutritional support aims to reverse these processes. Covering energy requirements is necessary for safety of anti-cancer treatments: radiotherapy, chemotherapy, surgery. Nutritional support and nutritional status monitoring should be managed at every stage of the disease. Nutritional intervention is most important in malnourished patients. Comprehensive, individualized nutritional care improves the results of treatment in cancer patients. Nutritional therapy is essential in obtaining the best results from anti-cancer treatment; however, it will be effective, if should completely cover nutrient requirements.

Article available in PDF format

View PDF Download PDF file

References

  1. Sobotka L. Basics in clinical nutrition. 4th ed. Galen 2012.
  2. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017; 36(1): 11–48.
  3. Kapała A. Nutritional therapy during the treatment of head and neck cancer. Oncol Clin Pract. 2018; 14(2): 79–85.
  4. Weimann A, Braga M, Carli F, et al. ESPEN guideline: Clinical nutrition in surgery. Clin Nutr. 2017; 36(3): 623–650.
  5. Li ZQ, Zou L, Liu TR, et al. Prognostic value of body mass index before treatment for laryngeal squamous cell carcinoma. Cancer Biol Med. 2015; 12(4): 394–400.
  6. Cao Dx, Wu Gh, Zhang Bo, et al. Resting energy expenditure and body composition in patients with newly detected cancer. Clin Nutr. 2010; 29(1): 72–77.
  7. Moses AWG, Slater C, Preston T, et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer. 2004; 90(5): 996–1002.
  8. Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999; 134(12): 1309–1316.
  9. Jankowski M, Las-Jankowska M, Sousak M, et al. Contemporary enteral and parenteral nutrition before surgery for gastrointestinal cancers: a literature review. World J Surg Oncol. 2018; 16(1): 94.
  10. Mauskopf JA, Candrilli SD, Chevrou-Séverac H, et al. Immunonutrition for patients undergoing elective surgery for gastrointestinal cancer: impact on hospital costs. World J Surg Oncol. 2012; 10: 136.
  11. Langius JAE, Zandbergen MC, Eerenstein SEJ, et al. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review. Clin Nutr. 2013; 32(5): 671–678.
  12. Paccagnella A, Morassutti I, Rosti G. Nutritional intervention for improving treatment tolerance in cancer patients. Curr Opin Oncol. 2011; 23(4): 322–330.
  13. Lu Z, Yang Li, Yu J, et al. Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance? PLoS One. 2014; 9(2): e88553.
  14. Martin L, Senesse P, Gioulbasanis I, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015; 33(1): 90–99.
  15. Rimar KJ, Glaser AP, Kundu S, et al. Changes in Lean Muscle Mass Associated with Neoadjuvant Platinum-Based Chemotherapy in Patients with Muscle Invasive Bladder Cancer. Bladder Cancer. 2018; 4(4): 411–418.
  16. de Las Peñas R, Majem M, Perez-Altozano J, et al. SEOM clinical guidelines on nutrition in cancer patients (2018). Clin Transl Oncol. 2019; 21(1): 87–93.
  17. Fearon K, Strasser F, Anker S, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12(5): 489–495.
  18. Penet MF, Bhujwalla ZM. Cancer cachexia, recent advances, and future directions. Cancer J. 2015; 21(2): 117–122.
  19. Castillo-Martinez L, et al. Nutritional assesment tools for the identification of malnutrition and nutritional risk associated with cancer treatment. rev Inves Clin. 2018; 70: 121–125.
  20. Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle. 2020; 11(2): 366–380.
  21. Ravasco P. Nutrition in Cancer Patients. J Clin Med. 2019; 8(8).
  22. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017; 36(1): 11–48.
  23. Blum D, Stene GB, Solheim TS, et al. Euro-Impact. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol. 2014; 25(8): 1635–1642.
  24. Mantovani G, Macciò A, Bianchi A, et al. Megestrol acetate in neoplastic anorexia/cachexia: clinical evaluation and comparison with cytokine levels in patients with head and neck carcinoma treated with neoadjuvant chemotherapy. Int J Clin Lab Res. 1995; 25(3): 135–141.
  25. Silver HJ, Dietrich MS, Murphy BA. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck. 2007; 29(10): 893–900.
  26. Williams JD, Wischmeyer PE. Assessment of perioperative nutrition practices and attitudes-A national survey of colorectal and GI surgical oncology programs. Am J Surg. 2017; 213(6): 1010–1018.
  27. Sriram K, Sulo S, VanDerBosch G, et al. A Comprehensive Nutrition-Focused Quality Improvement Program Reduces 30-Day Readmissions and Length of Stay in Hospitalized Patients. JPEN J Parenter Enteral Nutr. 2017; 41(3): 384–391.
  28. Wischmeyer PE, Carli F, Evans DC, et al. Perioperative Quality Initiative (POQI) 2 Workgroup. American Society for Enhanced Recovery and Perioperative Quality Initiative Joint Consensus Statement on Nutrition Screening and Therapy Within a Surgical Enhanced Recovery Pathway. Anesth Analg. 2018; 126(6): 1883–1895.
  29. Greco M, Capretti G, Beretta L, et al. Enhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials. World J Surg. 2014; 38(6): 1531–1541.
  30. Gustafsson UO, Oppelstrup H, Thorell A, et al. Adherence to the ERAS protocol is Associated with 5-Year Survival After Colorectal Cancer Surgery: A Retrospective Cohort Study. World J Surg. 2016; 40(7): 1741–1747.
  31. Kłęk S, Jankowski M, Kruszewski WJ, et al. Clinical nutrition in oncology: Polish recommendations. Nowotwory. Journal of Oncology. 2015; 11(4): 173–190.
  32. Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019; 393(10188): 2312–2321.



Nowotwory. Journal of Oncology